4egi 1
4EGI-1 is a small molecule inhibitor that acts as a potent and selective inhibitor of the eIF4E-eIF4G interaction. It disrupts the eIF4F complex formation, thereby inhibiting cap-dependent translation initiation.
Lab products found in correlation
6 protocols using 4egi 1
Mouse Hematopoietic Stem Cell Culture
Characterizing eIF4E-eIF4G and 4EBP1 Interactions
Regulation of MAP2B Protein Localization
Compound Potency Evaluation by Dose-Response Assays
Dose-response matrixes (checkerboard assays) were performed in a similar manner except that the titers of 2-fold serial dilutions of compound 1 (indicated along the x axis of the checkerboard) and compound 2 (indicated along the y axis) were determined. Values representing the fractional inhibitory concentration index at 90% growth inhibition (FICI90) were calculated as previously described (68 (link)).
BU-CMD hit compounds were newly supplied and dissolved in DMSO, 4EGI-1 (Tocris Biosciences) and rapamycin (BioShop) were dissolved in DMSO, fluconazole (Sequoia Research Products) was dissolved in sterile double-distilled water (ddH2O), and calcium chloride (BioShop) was used to supplement yeast nitrogen base (YNB) media, as indicated.
Establishing an in vitro model of neurodegeneration
Inhibition of eIF4F Complex Formation
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!